Core Viewpoint - The meeting between Jiangxi Biotechnology Vocational College and Aonong Group focused on collaboration between academia and industry, integration of education and production, and talent cultivation [1][3][6]. Group 1: Meeting Overview - Jiangxi Biotechnology Vocational College's Party Secretary, Yao Lihua, visited Aonong Group's Zhangzhou Technology Park for discussions on cooperation [1][6]. - Aonong Group's Vice Chairman and General Manager, Wu Youlin, welcomed the visit and highlighted the company's current business layout, development status, and talent needs [3][8]. Group 2: Collaboration and Talent Development - Yao Lihua acknowledged Aonong Group's achievements in industrial development and management, emphasizing the importance of deepening school-enterprise collaboration [4][10]. - The college aims to enhance practical training, talent delivery, and recruitment connections to facilitate high-quality employment for students [4][10]. Group 3: Cultural Exchange - Prior to the meeting, guests toured Aonong Group's corporate culture exhibition hall to understand the company's development history, business layout, and corporate culture [11]. - This exchange strengthened mutual understanding and laid a solid foundation for future cooperation and integration of education and industry [11].

Market Overview - The feed sector experienced a decline of 2.43% on February 2, with Da Bei Nong leading the drop [1] - The Shanghai Composite Index closed at 4015.75, down 2.48%, while the Shenzhen Component Index closed at 13824.35, down 2.69% [1] Individual Stock Performance - Da Bei Nong (002385) closed at 4.13, down 10.02%, with a trading volume of 4.442 million shares and a transaction value of 1.858 billion yuan [1] - Ao Nong Biological (603363) closed at 4.11, down 5.73%, with a trading volume of 793,800 shares and a transaction value of 331 million yuan [1] - Jin Xin Nong (002548) closed at 6.45, down 3.87%, with a trading volume of 501,200 shares and a transaction value of 331 million yuan [1] - Tian Ma Technology (603668) closed at 14.85, down 3.70%, with a trading volume of 189,100 shares and a transaction value of 283 million yuan [1] - Other notable declines include Bang Ji Technology (603151) down 3.62% and Tian Kang Biological (002100) down 3.31% [1] Capital Flow Analysis - The feed sector saw a net outflow of 338 million yuan from main funds, while retail investors contributed a net inflow of 249 million yuan [1] - The table indicates that Hai Da Group (002311) had a main fund net inflow of 5.8557 million yuan, while other companies like Lu Si Co. (920419) experienced significant net outflows [2] - Retail investors showed a net inflow in several stocks, including Bang Ji Technology (603151) with 262.63 million yuan [2]

福建傲农生物科技集团股份有限公司 2025年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 业绩预告的具体适用情形：实现盈利，且净利润与上年同期相比下降50%以上。 ● 福建傲农生物科技集团股份有限公司（以下简称"公司"）预计2025年年度实现归属于上市公司股东的 净利润为9,000万元到13,500万元，与上年同期相比，将减少44,434.50万元到48,934.50万元，同比减少 76.70%到84.47%。 一、本期业绩预告情况 （一）业绩预告期间 证券代码：603363 证券简称：傲农生物（维权） 公告编号：2026-006 2025年1月1日至2025年12月31日。 （二）业绩预告情况 1、经财务部门初步测算，预计2025年年度实现归属于上市公司股东的净利润为9,000万元到13,500万 元，与上年同期相比，将减少44,434.50万元到48,934.50万元，同比减少76.70%到84.47% 2、经财务部门初步测算，预计2025年年度实现归属于上市公司股东的扣除非经常性损益的 ...

Group 1 - The core viewpoint of the article is that Aonong Bio expects significant improvements in its financial performance and operational efficiency following its restructuring by the end of 2024 [1] - The company anticipates a net profit attributable to shareholders of 579.35 million yuan for 2024 and projects a net profit of between 90 million yuan and 135 million yuan for 2025 [1] - Aonong Bio plans to focus on its strategic initiatives of enhancing feed production, optimizing pig farming, and developing food products to create value for the industry and investors [1] Group 2 - The company is considering implementing measures such as dividends, share buybacks, and acquisitions to enhance its investment value and increase returns for investors, in compliance with legal regulations [1]

证券日报网讯1月30日，傲农生物（603363）发布公告称，公司预计2025年年度实现归属于上市公司股 东的净利润为9，000万元到13，500万元，与上年同期相比，将减少44，434.50万元到48，934.50万元， 同比减少76.70%到84.47%。 ...

Core Viewpoint - Aonong Biological (603363.SH) forecasts a significant decline in net profit for the year 2025, projecting a range of 90 million to 135 million yuan, which represents a decrease of 76.70% to 84.47% compared to the previous year [1] Group 1: Financial Performance - The expected net profit for 2025 is between 90 million and 135 million yuan, a decrease of 44.4345 million to 48.9345 million yuan from the previous year [1] - The decline in profit is attributed to the company's first year post-restructuring, with some assets still not operational, leading to depreciation and amortization costs of approximately 80 million yuan [1] Group 2: Operational Changes - The company has undergone bankruptcy restructuring, significantly reducing its debt and interest expenses year-on-year [1] - Aonong has divested some idle assets and is in the process of resuming operations at its breeding farms, with a rapid recovery in the sow inventory and improved production performance [1] - Major business segments, including pig farming, feed, and slaughtering, have shown signs of recovery and restructuring, solidifying the operational foundation [1] Group 3: Loss Provisions - The company has made provisions for bad debts and asset impairments amounting to approximately 200 million yuan for the year [1] - The benefits from debt restructuring are expected to decline significantly compared to 2024 [1]

Core Viewpoint - Aonong Biological (603363.SH) forecasts a significant decline in net profit for the year 2025, estimating a range of 90 million to 135 million yuan, which represents a decrease of 444.35 million to 489.35 million yuan compared to the previous year, equating to a year-on-year decline of 76.70% to 84.47% [1] Summary by Categories Financial Performance - The company expects a net profit attributable to shareholders of 90 million to 135 million yuan for 2025, a substantial decrease from the previous year [1] - The anticipated decline in profit is attributed to a reduction in debt scale and interest expenses due to bankruptcy restructuring, alongside significant losses from asset impairment and bad debt provisions totaling approximately 200 million yuan [1] Operational Developments - Following bankruptcy restructuring, the company has seen a significant reduction in debt and interest expenses, with some idle assets divested and core pig farming operations gradually resuming [1] - The company reports a rapid recovery in sow inventory and improved production performance across its main business segments, including pig farming, feed, and slaughtering [1] Asset Management - The first year post-restructuring has resulted in some assets still not being operational, leading to depreciation and amortization costs of about 80 million yuan for the year [1] - The benefits from debt restructuring are expected to decline significantly compared to 2024, impacting overall financial performance [1]

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603363 | 傲农生物 | 4.36 | 5.06% | 136.21万 | | 5.90亿 | | 002385 | 大北农 | 4.59 | 3.85% | 516.81万 | | 23.84亿 | | 603151 | 邦基科技 | 19.91 | 3.70% | 7.81万 | | 1.56亿 | | 688156 | 路德科技 | 19.27 | 2.77% | - 3.27万 | 6154.01万 | | | 300673 | 佩蒂股份 | 17.73 | 2.01% | 5.53万 | 9748.25万 | | | 002696 | 自洋股份 | 7.62 | 1.33% | 11.42万 | 8672.49万 | | | 001313 | 刻思想聞 | 7.89 | 1.28% | 13.47万 | | 1.06亿 | | 001366 | 播恩集团 | 14.10 | 1.15% | 4.07万 | 5701. ...

证券代码：603363 证券简称：傲农生物 公告编号：2026-007 福建傲农生物科技集团股份有限公司 2025 年 12 月公司担保情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、担保情况概述 福建傲农生物科技集团股份有限公司（以下简称"公司"或"本公司"）于 2025 年 3 月 28 日召开的第四届董事会第十二次会议和 2025 年 4 月 14 日召开的 2025 年第二次临时股东大会审议通过了《关于 2025 年度为产业链合作伙伴提供 担保的议案》、《关于 2025 年度公司及下属子公司相互提供担保的议案》，内 容包括： 1、同意公司及下属子公司 2025 年度为公司及下属子公司的下游客户、产业 链供应商、公司养殖放养业务的合作养户等产业链合作伙伴提供不超过 8 亿元的 担保。 截至 2025 年 12 月 31 日，公司及下属子公司为产业链合作伙伴提供的担保 余额前五名的情况如下： | 序号 | 被担保方与 公司关系 | 担保责 任余额 | 主债务 履行期 限 | 担保方式 | 融资用途 | 担保 ...

证券代码：603363 证券简称：傲农生物 公告编号：2026-006 福建傲农生物科技集团股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 业绩预告的具体适用情形：实现盈利，且净利润与上年同期相比下降 50% 以上。 福建傲农生物科技集团股份有限公司（以下简称"公司"）预计 2025 年年 度实现归属于上市公司股东的净利润为 9,000 万元到 13,500 万元，与上年同期相 比，将减少 44,434.50 万元到 48,934.50 万元，同比减少 76.70%到 84.47%。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 1、经财务部门初步测算，预计 2025 年年度实现归属于上市公司股东的净利 润为 9,000 万元到 13,500 万元，与上年同期相比，将减少 44,434.50 万元到 48,934.50 万元，同比减少 76.70%到 84.47% 2、经财务部门初步测算， ...